Reporting Form ARF 222.0
Exposures to Related Entities
Instruction Guide
This instruction guide is designed to assist in the completion of Reporting Form ARF 222.0 Exposures to related entities (ARF 222.0). This form collects information on an authorised deposit-taking institution’s (ADI’s) exposures to related entities.
In completing this form, ADIs must refer to Prudential Standard APS 222 Associations with Related Entities (APS 222).
General directions and notes
Reporting entity
ARF 222.0 must be completed on a Level 1 basis by all ADIs, with the exception of:
(a) foreign ADIs; and
(b) providers of purchased payment facilities.
Securitisation deconsolidation principle
- Where an ADI (or a member of its Level 2 consolidated group) participates in a securitisation that meets APRA’s operational requirements for regulatory capital relief under Prudential Standard APS 120 Securitisation (APS 120):
(a) special purpose vehicles (SPVs) holding securitised assets may be treated as non-consolidated independent third parties for regulatory reporting purposes, irrespective of whether the SPVs (or their assets) are consolidated for accounting purposes; and
(b) the assets, liabilities, revenues and expenses of the relevant SPVs may be excluded from the ADI’s reported amounts in APRA’s regulatory reporting returns.
- Where an ADI (or a member of its Level 2 consolidated group) participates in a securitisation that does not meet APRA’s operational requirements for regulatory capital relief under APS 120, or the ADI undertakes a funding-only securitisation or synthetic securitisation, such assets are to be reported as on-balance sheet in APRA’s regulatory reporting returns.
Securitisation exclusions
Funding-only securitisations that are self-securitisations are excluded from the reporting requirements in ARF 222.0.
Reporting period
This form is to be completed as at the last calendar day of each quarter based on the financial year (within the meaning of the Corporations Act 2001) of the ADI.
Unit of measurement
ADIs must complete the form in whole Australian dollars (no decimal place).
Amounts denominated in foreign currency must be converted to AUD in accordance with Accounting Standard AASB 121 The Effects of Changes in Foreign Exchange Rates (AASB 121).
Basis of preparation
For the purposes of this form, ADIs must report all exposures including both the effect of Credit risk mitigation (CRM) techniques (item 1) as well as on the basis of excluding the effect of CRM techniques (item 2), in accordance with Prudential Standard APS 221 Large Exposures (APS 221).
In completing this form, ADIs must apply the requirements for netting specified in Attachment A to APS 221.
Definitions
Terms highlighted in bold italics indicate that the definition is provided in these instructions.
Credit risk mitigation (CRM) means the CRM techniques allowed in Prudential Standard APS 112 Capital Adequacy: Standardised Approach to Credit Risk (APS 112).
ELE subsidiary has the meaning given in paragraph 8(c) of APS 222.
ELE subsidiary country means the country where the ELE subsidiary is domiciled. ADIs are to report the English name of the relevant country as assigned by the ISO 3166 Maintenance Agency to a country code defined under the International Organization for Standardization’s International Standard ISO 3166. The ISO 3166 Maintenance Agency maintains a free online browsing platform setting out the names of countries and their corresponding codes, available at https://www.iso.org/obp/ui/#search/code/.
ELE subsidiary name means the legal name of the ELE subsidiary.
Excluded exposures means exposures excluded from large exposures under paragraph 18 of APS 221.
Exposure means an ADI’s exposure to a related entity within the meaning given in paragraph 34 of APS 222, and measured in accordance with paragraphs 35 to 37 of APS 222.
Legal Entity Identifier is a 20-digit, alpha-numeric code issued by a Local Operating Unit in accordance with the International Organization for Standardization’s International Standard ISO 17442. The Global Legal Entity Identifier Foundation maintains a free online searchable database of Legal Entity Identifiers, available at https://search.gleif.org/#/search/.
Market related means off-balance sheet exposures arising from market related contracts.
Non-market related means off-balance sheet exposures that are not market related.
Off-balance sheet exposures means the off-balance sheet portion of any exposure, measured in accordance with Attachment A to APS 221.
On-balance sheet exposures means the on-balance sheet portion of any exposure, measured in accordance with Attachment A to APS 221.
Related ADI means a related entity which is an ADI.
Related entity has the meaning given in paragraph 8(f) of APS 222.
Related entity name means the legal name of the related entity.
Related entity sector means the sector of the related entity of the exposure. These are:
• banking;
• insurance;
• superannuation;
• SPVs;
• other financial institutions; and
• other counterparties.
Settlement exposures has the meaning given in paragraph 18(g) of APS 221.
Substantial shareholder has the meaning given in paragraph 8(i) of APS 222.
Substantial shareholder name means the legal name of the substantial shareholder.
Tier 1 Capital has the meaning given in Prudential Standard APS 111 Capital Adequacy: Measurement of Capital (APS 111).
Related entity category
Regulated means the related entity is regulated by APRA or an equivalent banking, superannuation or insurance prudential regulator overseas.
Non-regulated means the related entity is not regulated by APRA or an equivalent banking, superannuation or insurance prudential regulator overseas.
Related entity sectors
Banking institution means an ADI or banking institutions authorised in another jurisdiction.
Insurance corporations means:
• life insurance corporations registered under the Life Insurance Act 1995;
• general insurance corporations authorised under the Insurance Act 1973 (or by virtue of determinations made by APRA under the General Insurance Reform Act 2001);
• private health insurance corporations registered under the Private Health Insurance (Prudential Supervision) Act 2015;
• the Export Finance Insurance Corporation;
• private sector and government-owned general and health insurance enterprises, both proprietary and mutual; and
• any overseas insurance corporation.
Other counterparties includes any related entity that is not a banking institution, an SPV, insurance corporation, superannuation fund or other financial institution.
Other financial institutions means all entities mainly engaged in financial intermediation and the provision of auxiliary financial services, other than banking institutions, insurance corporations, and superannuation funds.
SPV means Special Purpose Vehicle.
Superannuation funds means complying funds for the purposes of the Superannuation Industry (Supervision) Act 1993, other autonomous funds established for the benefit of public sector employees and any overseas funds designed specifically for the purpose of providing a pension or other income stream on retirement.
Specific instructions
Section A: Exposures to related entities
| Item 1 | Report the twenty largest exposures to related entities as as at the end of the reporting period regardless of their size in proportion to Tier 1 Capital. Also report all exposures to related entities which exceed or are equal to 10 per cent of Tier 1 Capital.In column 1, report the related entity name for each exposure to a related entity.In column 2, report the Legal Entity Identifier of the related entity for each exposure to a related entity. Otherwise, report N/A if the related entity has no Legal Entity Identifier.In column 3, report the related entity category of the related entity for each exposure.In column 4, report the related entity sector of the related entity for each exposure.In column 5, report the on-balance sheet exposures that relate to the book value of all equity investments in the related entity. Exclude any equity investment in the related entity that has been deducted from the ADI’s Level 1 (stand-alone) capital for capital adequacy purposes (refer to APS 111).In column 6, report the on-balance sheet exposures that do not relate to equity investments in the related entity for each exposure.In column 7, report the non-market related, off-balance sheet exposures for the related entity for each exposure.In column 8, report the market related, off-balance sheet exposures for the related entity for each exposure.Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the related entity.Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6. |
|---|
| Item 2 | Report the twenty largest exposures to related entities as as at the end of the reporting period regardless of their size in proportion to Tier 1 Capital. Also report all exposures to related entities which exceed or are equal to 10 per cent of Tier 1 Capital, before CRM.In column 1, report the related entity name for each exposure to a related entity.In column 2, report the Legal Entity Identifier of the related entity for each exposure to a related entity. Otherwise, report N/A if the related entity has no Legal Entity Identifier.In column 3, report the related entity category of the related entity for each exposure.In column 4, report the related entity sector of the related entity for each exposure.In column 5, report the on-balance sheet exposures that relate to the book value of all equity investments in the related entity, before CRM. Exclude any equity investment in the related entity that has been deducted from the ADI’s Level 1 (stand-alone) capital for capital adequacy purposes (refer to APS 111).In column 6, report the on-balance sheet exposures that do not relate to equity investments in the related entity for each exposure, before CRM.In column 7, report the non-market related, off-balance sheet exposures for the related entity for each exposure, before CRM.In column 8, report the market related, off-balance sheet exposures for the related entity for each exposure, before CRM.Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the related entity, before CRM.Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6. |
Section B: Extended Licensed Entity (ELE)
| Item 3 | Report ADI exposures to all ELE subsidiaries as at the end of the reporting period.In column 1, report the ELE subsidiary name for each exposure.In column 2, report the Legal Entity Identifier of the ELE subsidiary for each exposure. Otherwise, report N/A if the ELE subsidiary has no Legal Entity Identifier.In column 3, report the ELE subsidiary country of the ELE subsidiary for each exposure, using the country list.In column 4, report the on-balance sheet exposures that relate to the book value of all equity investments in the ELE subsidiary.In column 5, report the on-balance sheet exposures that do not relate to equity investments in the ELE subsidiary for each exposure.In column 6, report the non-market related, off-balance sheet exposures for the ELE subsidiary for each exposure.In column 7, report the market related, off-balance sheet exposures for the ELE subsidiary for each exposure.Column 8 is derived as the total of columns 4, 5, 6 and 7 being the total exposure for the ELE subsidiary.Column 9 is derived as the ratio of column 8 to Tier 1 Capital reported in item 6. |
|---|
| Item 3.1 | Item 3.1 is derived as the total of the ADI exposures to all ELE subsidiaries.Columns 4, 5, 6, 7 and 8 of item 3.1 are derived as the sum of columns 4, 5, 6, 7 and 8 of item 3 respectively.Column 9 of item 3.1 is derived as the ratio of column 8 of item 3.1 to Tier 1 Capital reported in item 6. |
| Item 4 | Report exposures of all ELE subsidiaries which are established to hold or invest in assets, as at the end of the reporting period.In column 1, report the ELE subsidiary name for each exposure.In column 2, report the Legal Entity Identifier of the ELE subsidiary for each exposure. Otherwise, report N/A if the ELE subsidiary has no Legal Entity Identifier.In column 3, report the ELE subsidiary country of the ELE subsidiary for each exposure, using the country list.In column 4, report the on-balance sheet exposures that relate to the book value of all loans and advances of the ELE subsidiary for each exposure, including any accrued income associated with the exposure (e.g. interest, dividends).In column 5, report the on-balance sheet exposures that do not relate to loans and advances of the ELE subsidiary.In column 6, report the non-market related, off-balance sheet exposures of the ELE subsidiary for each exposure.In column 7, report the market related, off-balance sheet exposures of the ELE subsidiary for each exposure.Column 8 is derived as the total of columns 4, 5, 6 and 7 being the total exposure of each ELE subsidiary.Column 9 is derived as the ratio of column 8 to Tier 1 Capital reported in item 6. |
| Item 4.1 | Item 4.1 is derived as the total of the exposures of all ELE subsidiaries.Columns 4, 5, 6, 7 and 8 of item 4.1 are derived as the sum of columns 4, 5, 6, 7 and 8 of item 4 respectively.Column 9 of item 4.1 is derived as the ratio of column 8 of item 4.1 to Tier 1 Capital reported in item 6. |
Section C: Excluded exposures
| Item 5 | Report excluded exposures to a related entity, relating to settlement exposures, exceeding or equal to 10 per cent of Tier 1 Capital, as at the end of the reporting period.In column 1, report the related entity name for each exposure.In column 2, report the Legal Entity Identifier of the related entity for each exposure to a related entity. Otherwise, report N/A if the related entity has no Legal Entity Identifier.In column 3, report the related entity category of the related entity for each exposure.In column 4, report the related entity sector of the related entity for each exposure.In column 5, report the on-balance sheet exposures that relate to the book value of all loans and advances to the related entity.In column 6, report the on-balance sheet exposures that do not relate to loans and advances to the related entity for each exposure.In column 7, report the non-market related, off-balance sheet exposures for the related entity for each exposure.In column 8, report the market related, off-balance sheet exposures for the related entity for each exposure.Column 9 is derived as the total of columns 5, 6, 7 and 8 being the total exposure for the related entity.Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6. |
|---|
Memorandum Items
| Item 6 | Report in item 6 the Tier 1 Capital at Level 1 as at the end of the reporting period. |
|---|
| Item 7 | Report in item 7 the aggregate exposure to all related ADIs, including overseas based equivalents. |
| Item 8 | Report in item 8 the aggregate exposure to all related entities other than related ADIs and related overseas based equivalents. |
| Item 8.1 | Report in item 8.1 the aggregate exposure to non-regulated related entities. |
Section D: Substantial Shareholdings
| Item 9 | In column 1, report the substantial shareholder name.In column 2, report the Legal Entity Identifier of the substantial shareholder, if applicable. Otherwise, report N/A if the substantial shareholder has no Legal Entity Identifier.In column 3, report the substantial shareholder’s percentage holding of the ADI’s share capital. |
|---|
| Item 10 | Report the movement of substantial shareholdings in the ADI where the movement during the quarter is equal to or greater than one percent of the shareholding.In column 1, report the substantial shareholder name.In column 2, report the Legal Entity Identifier of the substantial shareholder, if applicable. Otherwise, report N/A if the substantial shareholder has no Legal Entity Identifier.In column 3, report the percentage movement, during the quarter, in a substantial shareholder’s holdings if the movement is equal to or greater than one percent of the shareholding. Otherwise, report N/A. |